-
1
-
-
0033584440
-
The prevalence of hepatitis C virus infection in the United States, 1988 through 1994
-
Alter, M. J., D. Kruszon-Moran, O. V. Nainan, G. M. McQuillan, F. Gao, L. A. Moyer, R. A. Kaslow, and H. S. Margolis. 1999. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N. Engl. J. Med. 341:556-562.
-
(1999)
N. Engl. J. Med.
, vol.341
, pp. 556-562
-
-
Alter, M.J.1
Kruszon-Moran, D.2
Nainan, O.V.3
McQuillan, G.M.4
Gao, F.5
Moyer, L.A.6
Kaslow, R.A.7
Margolis, H.S.8
-
2
-
-
0037423405
-
Guidelines for laboratory testing and result reporting of antibody to hepatitis C virus
-
Alter, M. J., W. L. Kuhnert, L. Finelli, et al. 2003. Guidelines for laboratory testing and result reporting of antibody to hepatitis C virus. Morb. Mortal. Wkly. Rep. Recomm. Rep. 52:1-13, 15.
-
(2003)
Morb. Mortal. Wkly. Rep. Recomm. Rep.
, vol.52
, pp. 1-13
-
-
Alter, M.J.1
Kuhnert, W.L.2
Finelli, L.3
-
3
-
-
18444399247
-
Clinical utility of total HCV core antigen quantification: A new indirect marker of HCV replication
-
Bouvier-Alias, M., K. Patel, H. Dahari, S. Beaucourt, P. Larderie, L. Blatt, C. Hezode, G. Picchio, D. Dhumeaux, A. U. Neumann, J. G. McHutchison, and J. M. Pawlotsky. 2002. Clinical utility of total HCV core antigen quantification: a new indirect marker of HCV replication. Hepatology 36:211-218.
-
(2002)
Hepatology
, vol.36
, pp. 211-218
-
-
Bouvier-Alias, M.1
Patel, K.2
Dahari, H.3
Beaucourt, S.4
Larderie, P.5
Blatt, L.6
Hezode, C.7
Picchio, G.8
Dhumeaux, D.9
Neumann, A.U.10
McHutchison, J.G.11
Pawlotsky, J.M.12
-
4
-
-
0030058610
-
Hepatitis C virus (HCV) subtype prevalence in Chiang Mai, Thailand, and identification of novel subtypes of HCV major type 6
-
Doi, H., C. Apichartpiyakul, K.-I. Ohba, M. Mizokami, and H. Hotta. 1996. Hepatitis C virus (HCV) subtype prevalence in Chiang Mai, Thailand, and identification of novel subtypes of HCV major type 6. J. Clin. Microbiol. 34:569-574.
-
(1996)
J. Clin. Microbiol.
, vol.34
, pp. 569-574
-
-
Doi, H.1
Apichartpiyakul, C.2
Ohba, K.-I.3
Mizokami, M.4
Hotta, H.5
-
5
-
-
0000122573
-
PHYLIP-phylogeny inference package (version 3.2)
-
Felsenstein, J. 1989. PHYLIP-phylogeny inference package (version 3.2). Cladistics 5:164-166.
-
(1989)
Cladistics
, vol.5
, pp. 164-166
-
-
Felsenstein, J.1
-
6
-
-
0037179698
-
Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection
-
Fried, M. W., M. L. Shiffman, K. R. Reddy, C. Smith, G. Marinos, F. L. Goncales, Jr., D. Haussinger, M. Diago, G. Carosi, D. Dhumeaux, A. Craxi, A. Lin, J. Hoffman, and J. Yu. 2002. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N. Engl. J. Med. 347:975-982.
-
(2002)
N. Engl. J. Med.
, vol.347
, pp. 975-982
-
-
Fried, M.W.1
Shiffman, M.L.2
Reddy, K.R.3
Smith, C.4
Marinos, G.5
Goncales Jr., F.L.6
Haussinger, D.7
Diago, M.8
Carosi, G.9
Dhumeaux, D.10
Craxi, A.11
Lin, A.12
Hoffman, J.13
Yu, J.14
-
7
-
-
0030064877
-
Interferon treatment for chronic hepatitis C infection in hemophiliacs-influence of virus load, genotype, and liver pathology on response
-
Hanley, J. P., L. M. Jarvis, J. Andrews, R. Dennis, P. C. Hayes, J. Piris, R. Lee, P. Simmonds, and C. A. Ludlam. 1996. Interferon treatment for chronic hepatitis C infection in hemophiliacs-influence of virus load, genotype, and liver pathology on response. Blood 87:1704-1709.
-
(1996)
Blood
, vol.87
, pp. 1704-1709
-
-
Hanley, J.P.1
Jarvis, L.M.2
Andrews, J.3
Dennis, R.4
Hayes, P.C.5
Piris, J.6
Lee, R.7
Simmonds, P.8
Ludlam, C.A.9
-
8
-
-
18644366350
-
Infection with hepatitis C virus among intravenous-drug users: Prevalence, genotypes and risk-factor-associated behavior patterns in Thailand
-
Hansurabhanon, T., C. Jiraphongsa, P. Tunsakun, R. Sukbunsung, B. Bunyamanee, P. Kuirat, S. Meedsen, W. Waedeng, A. Theamboonlers, and Y. Poovorawan. 2002. Infection with hepatitis C virus among intravenous-drug users: prevalence, genotypes and risk-factor-associated behavior patterns in Thailand. Ann. Trop. Med. Parasitol. 96:615-625.
-
(2002)
Ann. Trop. Med. Parasitol.
, vol.96
, pp. 615-625
-
-
Hansurabhanon, T.1
Jiraphongsa, C.2
Tunsakun, P.3
Sukbunsung, R.4
Bunyamanee, B.5
Kuirat, P.6
Meedsen, S.7
Waedeng, W.8
Theamboonlers, A.9
Poovorawan, Y.10
-
9
-
-
0031757669
-
Multiple sequence alignment with Clustal X
-
Jeanmougin, F., J. D. Thompson, M. Gouy, D. G. Higgins, and T. J. Gibson. 1998. Multiple sequence alignment with Clustal X. Trends Biochem. Sci. 23:403-405.
-
(1998)
Trends Biochem. Sci.
, vol.23
, pp. 403-405
-
-
Jeanmougin, F.1
Thompson, J.D.2
Gouy, M.3
Higgins, D.G.4
Gibson, T.J.5
-
10
-
-
0030997911
-
Genotypic distribution of hepatitis C virus in different regions of Thailand
-
Kanistanon, D., M. Neelamek, T. Dharakul, and S. Songsivilai. 1997. Genotypic distribution of hepatitis C virus in different regions of Thailand. J. Clin. Microbiol. 35:1772-1776.
-
(1997)
J. Clin. Microbiol.
, vol.35
, pp. 1772-1776
-
-
Kanistanon, D.1
Neelamek, M.2
Dharakul, T.3
Songsivilai, S.4
-
11
-
-
0038307145
-
A new HCV core antigen assay based on disassociation of immune complexes: An alternative to molecular biology in the diagnosis of early HCV infection
-
Laperche, S., N. Le Marrec, N. Simon, F. Bouchardeau, C. Defer, M. Maniez-Montreuil, T. Levayer, J. P. Zappitelli, and J. J. Lefrere. 2003. A new HCV core antigen assay based on disassociation of immune complexes: an alternative to molecular biology in the diagnosis of early HCV infection. Transfusion 43:958-962.
-
(2003)
Transfusion
, vol.43
, pp. 958-962
-
-
Laperche, S.1
Le Marrec, N.2
Simon, N.3
Bouchardeau, F.4
Defer, C.5
Maniez-Montreuil, M.6
Levayer, T.7
Zappitelli, J.P.8
Lefrere, J.J.9
-
12
-
-
0038721688
-
Clinical relevance of total HCV core antigen testing for hepatitis C monitoring and for predicting patients' response to therapy
-
Maynard, M., P. Pradat, P. Berthillon, G. Picchio, N. Voirin, M. Martinot, P. Marcellin, and C. Trepo. 2003. Clinical relevance of total HCV core antigen testing for hepatitis C monitoring and for predicting patients' response to therapy. J. Viral Hepat. 10:318-323.
-
(2003)
J. Viral Hepat.
, vol.10
, pp. 318-323
-
-
Maynard, M.1
Pradat, P.2
Berthillon, P.3
Picchio, G.4
Voirin, N.5
Martinot, M.6
Marcellin, P.7
Trepo, C.8
-
13
-
-
0032547938
-
Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C
-
McHutchison, J. G., S. C. Gordon, E. R. Schiff, M. L. Shiffman, W. M. Lee, V. K. Rustgi, Z. D. Goodman, M.-H. Ling, S. Cort, and J. K. Albrecht for the International Hepatitis Interventional Therapy Group (IHIT). 1998. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. N. Engl. J. Med. 339:1485-1492.
-
(1998)
N. Engl. J. Med.
, vol.339
, pp. 1485-1492
-
-
McHutchison, J.G.1
Gordon, S.C.2
Schiff, E.R.3
Shiffman, M.L.4
Lee, W.M.5
Rustgi, V.K.6
Goodman, Z.D.7
Ling, M.-H.8
Cort, S.9
Albrecht, J.K.10
-
14
-
-
0030007595
-
Hepatitis C virus types 7, 8 and 9 should be classified as type 6 subtypes
-
Mizokami, M., T. Gojobori, K. Ohba, K. Ikeo, X. M. Ge, T. Ohno, E. Orito, and J. Y. Lau. 1996. Hepatitis C virus types 7, 8 and 9 should be classified as type 6 subtypes. J. Hepatol. 24:622-624.
-
(1996)
J. Hepatol.
, vol.24
, pp. 622-624
-
-
Mizokami, M.1
Gojobori, T.2
Ohba, K.3
Ikeo, K.4
Ge, X.M.5
Ohno, T.6
Orito, E.7
Lau, J.Y.8
-
15
-
-
0036829817
-
Use and interpretation of virological tests for hepatitis C
-
Pawlotsky, J. M. 2002. Use and interpretation of virological tests for hepatitis C. Hepatology 36:S65-S73.
-
(2002)
Hepatology
, vol.36
-
-
Pawlotsky, J.M.1
-
16
-
-
0030036975
-
Factors affecting treatment responses to interferon-α in chronic hepatitis C
-
Pawlotsky, J. M., F. Roudot-Thoraval, A. Bastie, F. Darthuy, J. Rémiré, J. M. Métreau, E. S. Zafrani, J. Duval, and D. Dhumeaux. 1996. Factors affecting treatment responses to interferon-α in chronic hepatitis C. J. Infect. Dis. 174:1-7.
-
(1996)
J. Infect. Dis.
, vol.174
, pp. 1-7
-
-
Pawlotsky, J.M.1
Roudot-Thoraval, F.2
Bastie, A.3
Darthuy, F.4
Rémiré, J.5
Métreau, J.M.6
Zafrani, E.S.7
Duval, J.8
Dhumeaux, D.9
-
17
-
-
0032585237
-
Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus
-
Poynard, T., P. Marcellin, S. S. Lee, C. Niederau, G. S. Minuk, G. Ideo, V. Bain, J. Heathcote, S. Zeuzem, C. Trepo, J. Albrecht, and the International Hepatitis Interventional Therapy Group. 1998. Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. Lancet 352:1426-1432.
-
(1998)
Lancet
, vol.352
, pp. 1426-1432
-
-
Poynard, T.1
Marcellin, P.2
Lee, S.S.3
Niederau, C.4
Minuk, G.S.5
Ideo, G.6
Bain, V.7
Heathcote, J.8
Zeuzem, S.9
Trepo, C.10
Albrecht, J.11
-
18
-
-
0033831605
-
Genetic epidemiology of hepatitis C virus throughout Egypt
-
Ray, S. C., R. R. Arthur, A. Carella, J. Bukh, and D. L. Thomas. 2000. Genetic epidemiology of hepatitis C virus throughout Egypt. J. Infect. Dis. 182:698-707.
-
(2000)
J. Infect. Dis.
, vol.182
, pp. 698-707
-
-
Ray, S.C.1
Arthur, R.R.2
Carella, A.3
Bukh, J.4
Thomas, D.L.5
-
19
-
-
0038417161
-
HIV prevalence and risks among injection and noninjection drug users in northern Thailand: Need for comprehensive HIV prevention programs
-
Razak, M. H., J. Jittiwutikarn, V. Suriyanon, T. Vongchak, N. Srirak, C. Beyrer, S. Kawichai, S. Tovanabutra, K. Rungruengthanakit, P. Sawanpanyalert, and D. D. Celentano. 2003. HIV prevalence and risks among injection and noninjection drug users in northern Thailand: need for comprehensive HIV prevention programs. J. Acquir. Immune Defic. Syndr. 33:259-266.
-
(2003)
J. Acquir. Immune Defic. Syndr.
, vol.33
, pp. 259-266
-
-
Razak, M.H.1
Jittiwutikarn, J.2
Suriyanon, V.3
Vongchak, T.4
Srirak, N.5
Beyrer, C.6
Kawichai, S.7
Tovanabutra, S.8
Rungruengthanakit, K.9
Sawanpanyalert, P.10
Celentano, D.D.11
-
20
-
-
0023375195
-
The neighbor-joining method: A new method for reconstructing phylogenetic trees
-
Saitou, N., and M. Nei. 1987. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol. Biol. Evol. 4:406-425.
-
(1987)
Mol. Biol. Evol.
, vol.4
, pp. 406-425
-
-
Saitou, N.1
Nei, M.2
-
21
-
-
0032954992
-
Establishment of the first international standard for nucleic acid amplification technology (NAT) assays for HCV RNA
-
Saldanha, J., N. Lelie, A. Heath, et al. 1999. Establishment of the first international standard for nucleic acid amplification technology (NAT) assays for HCV RNA. Vox Sang. 76:149-158.
-
(1999)
Vox Sang.
, vol.76
, pp. 149-158
-
-
Saldanha, J.1
Lelie, N.2
Heath, A.3
-
22
-
-
0027522145
-
Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region
-
Simmonds, P., E. C. Holmes, T.-A. Cha, S.-W. Chan, F. McOmish, B. Irvine, E. Beall, P. L. Yap, J. Kolberg, and M. S. Urdea. 1993. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J. Gen. Virol. 74:2391-2399.
-
(1993)
J. Gen. Virol.
, vol.74
, pp. 2391-2399
-
-
Simmonds, P.1
Holmes, E.C.2
Cha, T.-A.3
Chan, S.-W.4
McOmish, F.5
Irvine, B.6
Beall, E.7
Yap, P.L.8
Kolberg, J.9
Urdea, M.S.10
-
23
-
-
0030477741
-
Evolutionary analysis of variants of hepatitis C virus found in South-East Asia: Comparison with classifications based upon sequence similarity
-
Simmonds, P., J. Mellor, T. Sakuldamrongpanich, C. Nuchaprayoon, S. Tanprasert, E. C. Holmes, and D. B. Smith. 1996. Evolutionary analysis of variants of hepatitis C virus found in South-East Asia: comparison with classifications based upon sequence similarity. J. Gen. Virol. 77:3013-3024.
-
(1996)
J. Gen. Virol.
, vol.77
, pp. 3013-3024
-
-
Simmonds, P.1
Mellor, J.2
Sakuldamrongpanich, T.3
Nuchaprayoon, C.4
Tanprasert, S.5
Holmes, E.C.6
Smith, D.B.7
-
24
-
-
0034031613
-
Determinants of the quantity of hepatitis C virus RNA
-
Thomas, D. L., J. Astemborski, D. Vlahov, S. A. Strathdee, S. C. Ray, K. E. Nelson, N. Galai, K. R. Nolt, O. Laeyendecker, and J. A. Todd. 2000. Determinants of the quantity of hepatitis C virus RNA. J. Infect. Dis. 181:844-851.
-
(2000)
J. Infect. Dis.
, vol.181
, pp. 844-851
-
-
Thomas, D.L.1
Astemborski, J.2
Vlahov, D.3
Strathdee, S.A.4
Ray, S.C.5
Nelson, K.E.6
Galai, N.7
Nolt, K.R.8
Laeyendecker, O.9
Todd, J.A.10
-
25
-
-
0029791087
-
Effect of human immunodeficiency virus on hepatitis C virus infection among injecting drug users
-
Thomas, D. L., J. W. Shih, H. J. Alter, D. Vlahov, S. Cohn, D. R. Hoover, L. Cheung, and K. E. Nelson. 1996. Effect of human immunodeficiency virus on hepatitis C virus infection among injecting drug users. J. Infect. Dis. 174:690-695.
-
(1996)
J. Infect. Dis.
, vol.174
, pp. 690-695
-
-
Thomas, D.L.1
Shih, J.W.2
Alter, H.J.3
Vlahov, D.4
Cohn, S.5
Hoover, D.R.6
Cheung, L.7
Nelson, K.E.8
-
26
-
-
0029155350
-
Hepatitis C virus variants from Thailand classifiable into five novel genotypes in the sixth (6b), seventh (7c, 7d) and ninth (9b, 9c) major genetic groups
-
Tokita, H., H. Okamoto, P. Luengrojanakul, K. Vareesangthip, T. Chainuvati, H. Iizuka, F. Tsuda, Y. Miyakawa, and M. Mayumi. 1995. Hepatitis C virus variants from Thailand classifiable into five novel genotypes in the sixth (6b), seventh (7c, 7d) and ninth (9b, 9c) major genetic groups. J. Gen. Virol. 76:2329-2335.
-
(1995)
J. Gen. Virol.
, vol.76
, pp. 2329-2335
-
-
Tokita, H.1
Okamoto, H.2
Luengrojanakul, P.3
Vareesangthip, K.4
Chainuvati, T.5
Iizuka, H.6
Tsuda, F.7
Miyakawa, Y.8
Mayumi, M.9
-
27
-
-
0028998145
-
Clinical outcomes after transfusion-associated hepatitis C
-
Tong, M. J., N. S. El-Farra, A. R. Reikes, and R. L. Co. 1995. Clinical outcomes after transfusion-associated hepatitis C. N. Engl. J. Med. 332:1463-1466.
-
(1995)
N. Engl. J. Med.
, vol.332
, pp. 1463-1466
-
-
Tong, M.J.1
El-Farra, N.S.2
Reikes, A.R.3
Co, R.L.4
-
28
-
-
0037492890
-
Comparative evaluation of the total hepatitis C virus core antigen, branched-DNA, and Amplicor Monitor assays in determining viremia for patients with chronic hepatitis C during interferon plus ribavirin combination therapy
-
Veillon, P., C. Payan, G. Picchio, M. Maniez-Montreuil, P. Guntz, and F. Lunel. 2003. Comparative evaluation of the total hepatitis C virus core antigen, branched-DNA, and Amplicor Monitor assays in determining viremia for patients with chronic hepatitis C during interferon plus ribavirin combination therapy. J. Clin. Microbiol. 41:3212-3220.
-
(2003)
J. Clin. Microbiol.
, vol.41
, pp. 3212-3220
-
-
Veillon, P.1
Payan, C.2
Picchio, G.3
Maniez-Montreuil, M.4
Guntz, P.5
Lunel, F.6
-
29
-
-
0033023854
-
Persistence of viremia and the importance of long-term follow-up after acute hepatitis C infection
-
Villano, S. A., D. Vlahov, K. E. Nelson, S. Cohn, and D. L. Thomas. 1999. Persistence of viremia and the importance of long-term follow-up after acute hepatitis C infection. Hepatology 29:908-914.
-
(1999)
Hepatology
, vol.29
, pp. 908-914
-
-
Villano, S.A.1
Vlahov, D.2
Nelson, K.E.3
Cohn, S.4
Thomas, D.L.5
-
30
-
-
0031567749
-
Hepatitis C: Global prevalence
-
World Health Organization. 1997. Hepatitis C: global prevalence. Wkly. Epidemiol. Rec. 72:341-344.
-
(1997)
Wkly. Epidemiol. Rec.
, vol.72
, pp. 341-344
-
-
-
31
-
-
0037401622
-
Total HCV core antigen assay: A new marker of hepatitis C viremia for monitoring the progress of therapy
-
Zanetti, A. R., L. Romano, M. Brunetto, M. Colombo, G. Bellati, and C. Tackney. 2003. Total HCV core antigen assay: a new marker of hepatitis C viremia for monitoring the progress of therapy. J. Med. Virol. 70:27-30.
-
(2003)
J. Med. Virol.
, vol.70
, pp. 27-30
-
-
Zanetti, A.R.1
Romano, L.2
Brunetto, M.3
Colombo, M.4
Bellati, G.5
Tackney, C.6
|